Cargando…
_version_ 1783298532572135424
author Tsukune, Yutaka
Sasaki, Makoto
Odajima, Takeshi
Sunami, Kazutaka
Takei, Tomomi
Moriuchi, Yukiyoshi
Iino, Masaki
Isoda, Atsushi
Nakaya, Aya
Muta, Tsuyoshi
Miyake, Takaaki
Miyazaki, Koji
Shimizu, Takayuki
Nakajima, Kei
Igarashi, Aiko
Nagafuji, Koji
Kurihara, Taro
Aoyama, Tomonori
Sugimori, Hiroki
Komatsu, Norio
author_facet Tsukune, Yutaka
Sasaki, Makoto
Odajima, Takeshi
Sunami, Kazutaka
Takei, Tomomi
Moriuchi, Yukiyoshi
Iino, Masaki
Isoda, Atsushi
Nakaya, Aya
Muta, Tsuyoshi
Miyake, Takaaki
Miyazaki, Koji
Shimizu, Takayuki
Nakajima, Kei
Igarashi, Aiko
Nagafuji, Koji
Kurihara, Taro
Aoyama, Tomonori
Sugimori, Hiroki
Komatsu, Norio
author_sort Tsukune, Yutaka
collection PubMed
description
format Online
Article
Text
id pubmed-5802507
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58025072018-02-08 Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan Tsukune, Yutaka Sasaki, Makoto Odajima, Takeshi Sunami, Kazutaka Takei, Tomomi Moriuchi, Yukiyoshi Iino, Masaki Isoda, Atsushi Nakaya, Aya Muta, Tsuyoshi Miyake, Takaaki Miyazaki, Koji Shimizu, Takayuki Nakajima, Kei Igarashi, Aiko Nagafuji, Koji Kurihara, Taro Aoyama, Tomonori Sugimori, Hiroki Komatsu, Norio Blood Cancer J Correspondence Nature Publishing Group UK 2017-11-23 /pmc/articles/PMC5802507/ /pubmed/29167420 http://dx.doi.org/10.1038/s41408-017-0002-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Tsukune, Yutaka
Sasaki, Makoto
Odajima, Takeshi
Sunami, Kazutaka
Takei, Tomomi
Moriuchi, Yukiyoshi
Iino, Masaki
Isoda, Atsushi
Nakaya, Aya
Muta, Tsuyoshi
Miyake, Takaaki
Miyazaki, Koji
Shimizu, Takayuki
Nakajima, Kei
Igarashi, Aiko
Nagafuji, Koji
Kurihara, Taro
Aoyama, Tomonori
Sugimori, Hiroki
Komatsu, Norio
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title_full Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title_fullStr Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title_full_unstemmed Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title_short Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
title_sort incidence and risk factors of hepatitis b virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in japan
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802507/
https://www.ncbi.nlm.nih.gov/pubmed/29167420
http://dx.doi.org/10.1038/s41408-017-0002-2
work_keys_str_mv AT tsukuneyutaka incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT sasakimakoto incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT odajimatakeshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT sunamikazutaka incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT takeitomomi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT moriuchiyukiyoshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT iinomasaki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT isodaatsushi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT nakayaaya incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT mutatsuyoshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT miyaketakaaki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT miyazakikoji incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT shimizutakayuki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT nakajimakei incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT igarashiaiko incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT nagafujikoji incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT kuriharataro incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT aoyamatomonori incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT sugimorihiroki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan
AT komatsunorio incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan